NP49426a Transition Medicines
NP49426a Transition Medicines is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 22 Jun 2026. Budget: 61,847,781 GBP. Supply of Transition Medicines to NHS Scotland.
Opportunity overview
- Project name
- NP49426a Transition Medicines
- Donor
- The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Key details
- Opportunity start date
- Opportunity end date
- Proposed project start date
- Project location(s)
- United Kingdom
- Budget
- 61,847,781
- Currency
- UK Pound Sterling
Summary
Frequently asked questions
What is NP49426a Transition Medicines?
NP49426a Transition Medicines is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 22 Jun 2026. Budget: 61,847,781 GBP. Supply of Transition Medicines to NHS Scotland.
Who is funding NP49426a Transition Medicines?
NP49426a Transition Medicines is funded by The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland).
When is the deadline to apply for NP49426a Transition Medicines?
The application deadline is 22 Jun 2026 12:00 (UTC).
Where will the NP49426a Transition Medicines project take place?
The project location(s) are: United Kingdom.
What is the budget for NP49426a Transition Medicines?
The available budget is 61,847,781 GBP.
How can I apply for NP49426a Transition Medicines?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.